Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Magné

Showing results (1-10 of 270) with videos related to

Pageof 27
Sort By:
Bulletin Du Cancer|February 7, 2004
[Pharmacological consequences of the targeting of epidermal growth factor receptor]Gérard Milano, Nicolas Magné
Bulletin Du Cancer|May 19, 2005
[Targeted therapies: last focus on EGF receptor inhibitors in breast cancer]Nicolas Magné, Gérard Milano
Bulletin Du Cancer|January 3, 2006
[Targeted therapies and radiotherapy in colorectal cancer]David Azria, Nicolas Magné
Bulletin Du Cancer|April 26, 2021
[Use of telehealth services in the oncology setting: Daily routine and during sanitary crisis]Elisabeth Daguenet, Nicolas Magné
The Lancet. Oncology|August 7, 2007
Brachytherapy for genital-tract rhabdomyosarcomas in girls: technical aspects, reports, and perspectivesNicolas Magné, Christine Haie-Meder
Expert Review of Anticancer Therapy|May 18, 2010
21st International Congress on Anticancer TreatmentNicolas Magné, Cécile Pacaut, Cyrus Chargari
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 17, 2010
Clinical evidence on PET-CT for radiation therapy planning in cervix and endometrial cancersChristine Haie-Meder, Renaud Mazeron, Nicolas Magné
Cancer Investigation|September 5, 2022
COVID-19 Vaccine-Related Adverse Events in Solid Cancer Patients Treated with ImmunotherapyWafa Bouleftour, Paul Bonjean, Kevin Grangeon, et al.
Japanese Journal of Clinical Oncology|July 12, 2002
Disposition of radioiodine (131)I therapy for thyroid carcinoma in a patient with severely impaired renal function on chronic dialysis: a case reportNicolas Magné, Jacques Magné, Jean Bracco, et al.
Bulletin Du Cancer|May 20, 2015
[FGF/FGFR signalling: Implication in oncogenesis and perspectives]Ronan Flippot, Moumini Kone, Nicolas Magné, et al.
Pageof 27

Showing results (1-10 of 270) with videos related to

Sort By:
Pageof 27
Bulletin Du Cancer|February 7, 2004
[Pharmacological consequences of the targeting of epidermal growth factor receptor]Gérard Milano, Nicolas Magné
Bulletin Du Cancer|May 19, 2005
[Targeted therapies: last focus on EGF receptor inhibitors in breast cancer]Nicolas Magné, Gérard Milano
Bulletin Du Cancer|January 3, 2006
[Targeted therapies and radiotherapy in colorectal cancer]David Azria, Nicolas Magné
Bulletin Du Cancer|April 26, 2021
[Use of telehealth services in the oncology setting: Daily routine and during sanitary crisis]Elisabeth Daguenet, Nicolas Magné
The Lancet. Oncology|August 7, 2007
Brachytherapy for genital-tract rhabdomyosarcomas in girls: technical aspects, reports, and perspectivesNicolas Magné, Christine Haie-Meder
Expert Review of Anticancer Therapy|May 18, 2010
21st International Congress on Anticancer TreatmentNicolas Magné, Cécile Pacaut, Cyrus Chargari
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 17, 2010
Clinical evidence on PET-CT for radiation therapy planning in cervix and endometrial cancersChristine Haie-Meder, Renaud Mazeron, Nicolas Magné
Cancer Investigation|September 5, 2022
COVID-19 Vaccine-Related Adverse Events in Solid Cancer Patients Treated with ImmunotherapyWafa Bouleftour, Paul Bonjean, Kevin Grangeon, et al.
Japanese Journal of Clinical Oncology|July 12, 2002
Disposition of radioiodine (131)I therapy for thyroid carcinoma in a patient with severely impaired renal function on chronic dialysis: a case reportNicolas Magné, Jacques Magné, Jean Bracco, et al.
Bulletin Du Cancer|May 20, 2015
[FGF/FGFR signalling: Implication in oncogenesis and perspectives]Ronan Flippot, Moumini Kone, Nicolas Magné, et al.
Pageof 27